Abstract
Multi-purpose prevention technologies (MPTs) that aim to simultaneously prevent unintended pregnancy, human immunodeficiency virus type 1 (HIV-1) infection and other sexually transmitted infections (STIs) are among the most innovative and complex products currently in development within women’s sexual and reproductive healthcare. In this review article, MPTs are placed within the wider context of combination products, combination drug products and multi-indication products. The current MPT product landscape is mapped and assessed with reference to existing products for the corresponding single indications, before identifying the gaps in the current MPT product pipeline and highlighting priority products and challenges moving forward.
| Original language | English |
|---|---|
| Pages (from-to) | 62-69 |
| Number of pages | 8 |
| Journal | BJOG: An International Journal of Obstetrics and Gynaecology |
| Volume | 121 |
| Issue number | S5 |
| DOIs | |
| Publication status | Published - 21 Oct 2014 |
Keywords
- combination products
- contraception
- microbicide
- MPTs
Access to Document
- Beyond HIV microbicides: multipurpose prevention technology (MPT) products
© 2014 Royal College of Obstetricians and Gynaecologists This is the peer reviewed version of the following article: Malcolm RK, Boyd P, McCoy CF, Murphy DJ. Beyond HIV microbicides: multipurpose prevention technology products. BJOG 2014; 121 (Suppl. 5): 62–69, which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.12852/references. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.